Table 1 Baseline characteristics
Characteristics | Values |
|---|---|
Gender | |
Male, n (%) | 12 (75) |
Female, n (%) | 4 (25) |
Age, years | 60 (51.5, 62) |
BSA, m2 | 1.78 ± 0.16 |
BMI, kg/m2 | 26.1 ± 4.01 |
Hypertension, n (%) | 9 (56.3) |
Diabetes mellitus, n (%) | 5 (31.2) |
Hyperlipidemia, n (%) | 7 (43.8) |
Peripheral vascular disease, n (%) | 0 (0) |
Cerebrovascular disease, n (%) | 2 (12.5) |
Chronic pulmonary disease, n (%) | 1 (6.2) |
Prior myocardial infarction, n (%) | 8 (50) |
Atrial fibrillation, n (%) | 1 (6.2) |
Smoking, n (%) | 10 (62.5) |
LVEDD, mm | 49.6 ± 4.7 |
LVEF, % | 59.4 ± 6.3 |
Compression of LAD-MB, % | 63 ± 17.9 |
Length of MB, mm | 25.9 ± 16.3 |
Proximal stenosis of LAD, % | 89.6 ± 7.2 |
Medications | |
Aspirin, n (%) | 9 (56.3) |
Beta-blocker, n (%) | 10 (62.5) |
Calcium-channel blocker, n (%) | 1 (6.2) |
Nitrates, n (%) | 8 (50) |